Key result
The MnSOD Val/Ala+Ala/Ala genotype was significantly associated with an increased risk of coronary artery disease compared to the Val/Val genotype (OR 1.86; 95% CI 1.15-3.01).
Why the study?
Are polymorphisms of antioxidant genes (MnSOD, CAT, GPx1) associated with the risk of coronary artery disease?
Case-Control (n=657)
No
Are polymorphisms of antioxidant genes (MnSOD, CAT, GPx1) associated with the risk of coronary artery disease?
Odds Ratio: 1.86 (95% CI 1.15–3.01)
The MnSOD Val16Ala polymorphism is independently associated with an increased susceptibility to coronary artery disease in the Chinese population.
May support CAD risk stratification via MnSOD variants in Chinese adults; leaves open causal role and clinical utility pending prospective trials.
Objective . Reactive oxygen species (ROS) been cited as one of the major causes of atherosclerosis and coronary artery disease which are possible agents inducing DNA damage. Manganese superoxide dismutase (MnSOD), catalase (CAT), and glutathione peroxidase-1 (GPx1) have evolved to address primary defense against free radical mediated damage in mitochondria. The aim of this study was to delineate the association of MnSOD , CAT , and GPx1 polymorphisms and risk of CAD in Taiwan. Methods . We conducted a case-control study with 657 participants recruited at a medical center. All subjects were evaluated by noninvasive stress test and then quantitative coronary angiography to confirm the diagnosis of CAD. 447 CAD cases were defined as >50% stenosis of coronary artery and 210 controls were stenosed below 50%. Polymorphisms of MnSOD (Val16Ala), CAT (C-262T), and GPx1 (Pro198Leu) genes were determined by polymerase chain reaction methods. Multivariate logistic regression model was used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). Results . The MnSOD Val/Ala+Ala/Ala genotype was significantly associated with an increased risk of CAD compared to the Val/Val genotype (OR = 1.86, 95% CI = 1.15-3.01). This polymorphism was also associated with the severity of CAD of single and two vessel diseases. The corresponding ORs were 2.31 (95% CI = 1.32-4.03) and 1.92 (95% CI = 1.02-3.61), respectively. Among cigarette smokers, the harmful genetic effect of MnSOD Ala allele on CAD risk was much higher (OR = 2.23, 95% CI = 1.02-4.88). However, the interaction between MnSOD genotype and cigarette smoking on CAD risk was not significant. No significant association between CAT and GPx1 polymorphisms and CAD risk was observed. Conclusion . Our results suggest that MnSOD polymorphism is an independent risk factor for susceptibility to CAD in the Chinese population.
No takes yet. Share an insight, caveat, or question.
Yeh et al. (2018) conducted a case-control in Coronary Artery Disease (n=657). MnSOD Val/Ala+Ala/Ala genotype vs. MnSOD Val/Val genotype was evaluated on Risk of CAD (OR 1.86, 95% CI 1.15-3.01). The MnSOD Val/Ala+Ala/Ala genotype was significantly associated with an increased risk of coronary artery disease compared to the Val/Val genotype (OR 1.86; 95% CI 1.15-3.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: